Gene Query: NADK

Dataset Description Geneva Score
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 67.78
Genome wide expression change by RNF168 knocking down in NEC cells 33.17
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 30.29
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 26.92
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 22.85
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 20.96
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 20.41
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 19.56
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 19.12
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 18.85
Genome wide expression change by RNF168 knocking down in MCF-7 cells 17.19
Transcriptome of diurnal human blood neutrophils 17.16
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 16.98
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 16.41
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 16.41
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 16.29
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 16.05
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 15.97
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 15.79
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 15.79
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 15.56
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 15.29
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 15.27
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 15.27
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 14.7
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 13.86
Loss of CREBBP results in gene expression repression in lymphoma cells 13.86
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 13.65
Human cells contain natural double-stranded RNAs with potential regulatory capacity 13.52
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 13.31
Human neutrophil genome during PMA- and E. coli encounter-induced activation 13.31
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 13.09
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 13.09
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 13.02
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 12.89
IL-33 activates tumor stroma to promote intestinal polyposis 12.73
SUV420H2 knockdown in PANC-1 12.23
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 12.03
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 11.99
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 11.73
MYC dependent mRNA translation shapes gene expression and cell biology 11.6
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 11.59
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 11.44
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 11.44
AR-independent prostate cancer is sustained through FGF signaling 11.36
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 11.23
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 11.18
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 11.03
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 11.03
DART-seq: an antibody-free method for global m6A detection 10.93
Lipid degradation promotes prostate cancer cell survival 10.68
CircRNAome diversity in human mature B-cells, T-cells and monocytes 10.62
Global response to chemotherapy-induced apoptosis 10.61
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 10.46
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 10.28
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 10.28
Macrophage Ad5f35 M2 Challenge 10.23
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 10.23
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 10.03
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 9.98
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 9.98
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 9.82
FBXW7 modulates stress response by post-translational modification of HSF1 9.68
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 9.68
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 9.68
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 9.67
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 9.66
Region-specific Innate Antiviral Responses of the Human Epididymis 9.61
Genome-wide functional assessment of enhancer activities in the human genome 9.59
Paxillin regulates genomic networks in prostate cancer [PC3] 9.55
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 9.52
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 9.44
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 9.44
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 9.36
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 9.33
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 9.25
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 9.25
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.01
NHLRC1 re-expression in cancer cells 9.01
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 8.95
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 8.92
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 8.92
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 8.92
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 8.91
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 8.89
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.88
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 8.87
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 8.84
Co-transcriptional loading of RNA export factors shapes the human transcriptome 8.77
RNAseq of HEK293 cells after Chtop knockdown 8.77
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 8.76
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 8.71
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 8.64
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 8.61
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 8.57
High-Throughput Kinetic Analysis of Fractional Killing 8.56
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 8.49
Zone dependent distinctive gene expression profile of the normal human liver tissue 8.45
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 8.4
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 8.37
Widespread regulated alternative splicing of single codons accelerates proteome evolution 8.31
Generation and functional characterization of MDSC-like cells 8.26
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 8.24
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.23
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 8.19
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 8.09
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 8.07
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 8.07
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.06
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 7.99
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 7.95
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 7.95
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 7.9
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 7.9
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.88
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 7.87
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 7.76
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 7.75
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.71
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 7.7
miR941 overexpression experiment 7.68
Intron retention induced by microsatellite expansions as a disease biomarker. 7.66
TOP2B disturbed the quality of human oocytes with advanced maternal age 7.6
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 7.59
Identification of HOXB13 target genes responsive to BET inhibitors 7.59
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 7.59
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 7.59
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 7.57
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.54
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.37
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 7.37
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 7.37
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.37
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 7.37
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 7.34
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 7.34
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 7.24
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 7.21
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.2
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 7.18
EWSR1 influences alternative splicing through direct and indirect mechanisms 7.1
Endothelial gene expression analysis 7.09
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 7.09
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 7.06
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.06
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 7.04
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 7.03
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 7.03
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.0
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 6.98
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 6.98
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.91
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.91
PNET animal model: new insights (II) 6.9
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 6.89
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 6.88
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 6.88
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.81
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 6.81
MAIT cell RNA sequencing 6.8
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.79
RNA-seq of YB5 cells treated with Proscillaridin A 6.78
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 6.76
Spliceosomal disruption of the non-canonical BAF complex in cancer 6.74
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 6.73
RNA sequencing of primary human platelets and in vitro cell lines 6.72
MOF acetyl transferase regulates transcription and respiration in mitochondria 6.71
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 6.71
Expression profiling of MCF-7 cells with treatment of TCDD 6.68
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 6.68
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 6.66
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 6.66
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 6.64
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 6.63
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 6.58
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 6.58
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 6.54
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 6.54
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 6.53
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 6.49
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.45
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.45
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 6.45
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 6.4
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 6.39
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 6.39
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 6.39
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 6.32
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 6.32
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 6.32
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 6.28
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 6.28
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 6.24
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 6.23
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 6.22
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.17
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.17
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 6.17
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 6.15
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 6.15
Regulation of protein translation during mitosis 6.15
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 6.14
Transcriptional profile in human S. haematobium infection 6.14
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.1
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.1
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 6.09
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 6.07
RNA-seq of MDA-MB-231 cells with TET1 knockout 6.03
Genome-wide analysis of the Integrator complex (HTS) 6.01
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.99
RNA-seq analyisis of PUM2 knockout cells 5.98
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 5.97
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 5.85
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 5.84
Evaluating pre-clinical models for studying NASH driven HCC. 5.82
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 5.81
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.81
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 5.79
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.76
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 5.75
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 5.75
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 5.75
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 5.74
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 5.73
Functional role of SLIT2 and ROBO1 in trophoblasts 5.71
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.7
Gene expression changes after LOC550643 silencing 5.69
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.66
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.65
Transcription elongation regulates genome 3D structure 5.63
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 5.6
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 5.59
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 5.52
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 5.52
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 5.52
Leucegene: AML sequencing (part 6) 5.51
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 5.5
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 5.47
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 5.45
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 5.43
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 5.4
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 5.37
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 5.37
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 5.37
RNA transcriptome analysis during HSV-1 infection 5.34
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 5.3
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 5.3
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 5.27
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.25
RNA expression analysis upon JMJD1C depletion 5.25
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 5.24
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 5.23
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 5.21
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 5.21
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 5.21
RNA sequencing of human mammary epithelial cells 5.15
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 5.13
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 5.08
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 5.08
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 5.05
Landscape and variation of RNA secondary structure across the human transcriptome 5.03
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 4.98
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.98
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.98
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 4.97
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 4.97
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 4.97
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 4.95
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 4.94
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.92
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 4.84
Gene Expression Profiling of WT and KDM3A Knocked out Cell 4.84
Efficient derivation of microglia-like cells from human pluripotent stem cells 4.77
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 4.74
Macrophage Ad5f35 PhenoMap 4.72
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 4.7
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 4.7
HEK293 TFAM Knockout Expression Study 4.69
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 4.68
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.65
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 4.63
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.63
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 4.62
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 4.62
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 4.59
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 4.59
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.58
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 4.53
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 4.52
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 4.49
CD86 regulates a pro-survival signal in myeloma cells 4.42
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.42
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 4.42
Functional role of CPPED1 in trophoblasts. 4.39
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 4.38
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 4.34
High-throughput sequencing of pluripotent cells 4.33
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 4.33
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 4.28
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 4.28
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 4.28
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.27
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 4.22
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 4.22
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 4.21
DIGIT regulates endoderm differentiation of human embryonic stem cells 4.19
Illumina Total RNA-seq in HeLa 4.18
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 4.03
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 4.01
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 3.99
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.91
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 3.89
Identification of renal resident macrophages across species [C1] 3.88
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 3.86
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.79
Transciptomic profiling of human fetal lung samples 3.78
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 3.78
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.71
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 3.71
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 3.7
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 3.68
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 3.65
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.64
SNHG5 siRNA knock down in HCT116 cells 3.63
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.61
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 3.59
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 3.59
Trascriptome of thyroid cancer-induced macrophages 3.54
circRNA profile in hypopharyngeal cancer 3.46
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 3.45
RNA-sequencing of human tendon after injury 3.44
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.4
A20 regulates canonical wnt-signaling through an interaction with RIPK4 3.39
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.38
Overexpression and knockdown experiment for circCSNK1G3 3.37
Identification of renal resident macrophages across species 3.37
Gene expression analysis of human hepatocellular cancers 3.3
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.25
X-Ray induced DNA-Hydroxymethylation changes 3.23
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 3.21
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 3.2
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 3.2
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 3.2
Irf9 function in immunity in mouse 3.2
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 3.18
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.18
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.14
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 3.14
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 3.08
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 3.05
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.04
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 3.02
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 3.02
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 2.96
Searching for target genes of miR-508/509/506/514 in HCT116 cells 2.95
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 2.94
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 2.91
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 2.91
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 2.91
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.86
Ribosomal protein RPL26 is the principal target of UFMylation 2.84
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 2.83
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.81
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.77
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 2.72
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.71
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.7
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.7
Mapping interactions for the TNIP2 hub protein 2.66
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 2.64
DAOY-Notch1/Notch2 knockout: transcriptome comparison 2.55
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.49
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 2.47
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 2.45
Biological effect of chronic mistranslation in mammalian cells 2.41
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 2.37
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 2.37
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.35
Gene expression profile in breast cancer cells 2.35
Iron response of HepG2 cells 2.35
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.27
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.16
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.15
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 2.15
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.14
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.12
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.03
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 2.02
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 2.02
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.01
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.93
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.92
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.89
mRNA recovered upon RNF219 IP. [RNA-IP] 1.88
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.85
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.85
RNA-seq differential expression studies: more sequence, or more replication? 1.83
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 1.83
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.83
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.82
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.8
The pioneer factor CEBPA modulates vitamin D signaling 1.8
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.8
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.79
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.78
Induced DNA demethylation, genome instability and transcription 1.78
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.76
RNA-Sequencing of HepG2 cells treated with TGFBeta 1.76
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.76
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.74
H1609088 Human RNA-Sequencing 1.74
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.73
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.73
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.72
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.71
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.7
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.69
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 1.68
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 1.68
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.66
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.64
ChIP-seq and RNA-seq from human lymphoma cell lines 1.58
RNA-seq data from human lymphoma cell lines 1.58
Measure transcript integrity using RNA-seq data 1.56
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.56
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.54
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.53
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.52
Transcriptome analysis of peripheral blood monocytes 1.5
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.5
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.49
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 1.45
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 1.45
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.44
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.38
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.38
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.37
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.37
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.33
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.27
Transcriptome analysis upon C6orf203 silencing 1.22
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.2
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.2
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.2
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.19
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 1.17
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 1.17
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.17
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.17
miRNAs affected by antagomiR-17 treatment 1.16
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.07
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.07
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 1.06
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 1.04
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.04
Conservative alteration of chromosomal expression pattern across human solid tumor types 1.03
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.02
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 1.01
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.97
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.93
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.91
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.9
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.85
Comparative Analysis of Cas9 Activators Across Multiple Species 0.83
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.83
Clinker: visualizing fusion genes detected in RNA-seq data 0.83
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.78
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 0.73
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.73
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.73
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.71
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.71
Transposon-based construction of strand-specific RNA-seq libraries 0.7
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.65
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.59
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.59
The role of m6A/m-RNA methylation in stress response regulation 0.57
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.57
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 0.56
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.5
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.45
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.41
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.4
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.39
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.35
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.35
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.32
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.31
Cell responses to dysregulated VZV-induced cell-cell fusion 0.29
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.26
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 0.24
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.22
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.19
RNA-seq of primary patient AML samples 0.17
Function and hormonal regulation of GATA3 in human first trimester placentation 0.17
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.1
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.08
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.06
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.04
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation